ABSTRACT. We studied the pre-and postnatal developmental regulation of the hepatic type I IGF receptor in the rat. Fetal rat liver membranes bound IGF-I throughout the latter part of gestation (d 17 to 21). After birth, binding diminished rapidly, reaching barely detectable levels by the 13th postnatal d. However, the presence of type I IGF receptors was readily demonstrated by affinity-labeling throughout the immediate postnatal period and in adult rats. Furthermore, IGF-I-dependent autophosphorylation of type I receptors could be seen in both fetal and adult liver membranes. Fasting for 48 h in adult rats led to a 2-to 3-fold increase in affinity-labeled type I IGF receptors. In contrast, nutrient deprivation to the fetus, via maternal fasting, did not alter fetal hepatic IGF-I binding or affinitylabeling of the type I receptor. These results support a role for the IGF and the type I IGF receptor in the autocrinel paracrine regulation of hepatic growth through the latter stages of gestation in the rat. The demonstration of enzymatically active type I IGF receptors in adult liver, and their increased expression in fasted adult rats is consistent with an autocrine/paracrine 3de for hepatic IGF-I in the adult. (Pediatr Res 29: 226-230, 1991) polypeptide growth factors. Specific mRNA for IGF-I and IGF-I1 are present in fetal rat liver, with IGF-I1 predominating (7). Similarly, the mRNA for TGF-a, a homologue of EGF that acts through the EGF receptor (8), is present in fetal rat liver (9). However, the potential importance of TGF-a as a fetal hepatic growth factor in the rat is diminished by the finding that expression of the EGF receptor occurs late in gestation on d 20 (10). Another polypeptide growth factor, TGF-6, is probably synthesized in fetal liver (9, 11). It is, however, an inhibitor of DNA synthesis in rat fetal hepatocytes in primary cultures (Gruppuso P, unpublished observation). Just as we had done for the TGF, we decided to study the ontogeny of the type I IGF receptor to assess the potential role for the IGF in fetal hepatic growth and differentiation in the rat. Given the importance of nutritional factors in the regulation of IGF secretion (12), we also studied the effects of impaired intrauterine growth on hepatic type I IGF receptor expression. Finally, changes during the perinatal period were also examined, as was receptor expression in normal and fasted adult rats.
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MATERIALS AND METHODS
Pregnant Sprague-Dawley rats (Charles River Breeding LaboAbbreviations ratory, Wilmington, MA) were delivered by cesarean section on d 17 through 2 1 of gestation. Control dams (1 5 litters) were fed TGF, transforming growth factor standard laboratory food a d libitum. For the experimental group EGF, epidermal growth factor (four litters), mothers were fasted for 48 h before delivery on d IGFBP, IGF binding protein 21 while being given free access to water. Cesarean section was performed under pentobarbital anesthesia (50 mg/kg, intraperitoneally). With the placenta adherent to the uterus, the fetuses were exsanguinated via an axillary incision. Their livers were removed, flash frozen in liquid nitrogen, and stored at -70°C The effects of the mitogenic hormones IGF-I and IGF-11 can until Use. In addition, several rats were allowed to deliver sponbe mediated via binding to the type I IGF receptor (1). This taneously. Their PUPS were killed by decapitation under Pentotransmembrane glycoprotein is a heterotetramer with consider-barbital anesthesia 1, 2, 5, and 13 d after birth. Finally, adult able primary structure similarity to the insulin receptor (2) . Like male rats (1 25-1 50 g) were killed with or without prior fasting the insulin receptor, the type 1 IGF receptor a-subunit contains (ad libitum water intake) for 48 h. AS in previous studies from an extracellular, cysteine-rich ligand-binding domain, whereas our own laboratory ( 13, 14) , maternal fasting for 48 h led to fetal the P-subunit intracellular domain is a tyrosine-specific protein growth retardation with an -10% decrease in mean fetal carcass kinase capable of autophosphorylation (3) (4) (5) . This enzyme activ-weight and an -25% decrease in mean fetal liver weight. ity presumably is involved in signal transmission via phosphorylMembrane preparations were made as previously described ation of proteins exogenous. to the receptor. However, no func-(14) from the pooled livers from each litter or individual Posttionally defined exogenous substrates for this receptor have been natal livers. Yields of membrane protein Per unit wet weight defined as of yet. Although both IGF-I and IGF-11 can also bind were similar for all groups. Membranes were diluted to a protein to the type I1 IGF receptor (I), it has not been demonstrated content of 10 mg/mL and stored at -70°C until use. definitively that this M, = 274 000 monomer, which is identical Human IGF-I was obtained from Bachem, Inc. (-h"fance, to the cation-independent mannosed-phosphate receptor (6) , is CA , was based on the slope of a tangent drawn at 50% of maximal binding. Affinity-labeling of hepatic membranes was accomplished by incubation of labeled ligand (0.15 pCi; 300 pM, final concentration) and 240 pg membrane protein with or without unlabeled ligand in a total volume of 240 pL for 2 h at 15°C (buffers as for binding assays). Cross-linking was performed by the addition of 0.25 mM disuccinimidyl suberate followed by incubation on ice for 15 min. Membranes were collected by centrifugation (as for binding assays), suspended in gel electrophoresis sample buffer with reducing agent, and placed in a boiling water bath for 5 min. Samples (50 pg protein per lane) were analyzed by PAGE (6.5%, except where noted) in the presence of dodecyl sulfate. Molecular weights were determined using the following standards: myosin, M, = 200 000; @-galactosidase, 1 16 250; phosphorylase 6, 97 400; BSA, 66 200; ovalbumin, 42 700. Gels were exposed to Kodak XAR-5 film in the presence of intensifying screens at -70°C. Radiolabeled bands were quantified with a Hoefer model no. 300s scanning densitometer (Hoefer Scientific Instruments, San Francisco, CA) connected to a Hewlett-Packard model no. 3390A integrator (Hewlett-Packard Co., Palo Alto, CA).
To assess the contribution of membrane-associated IGFBP to membrane binding, we utilized analysis by Western ligand blot as described previously (16) . Briefly, membrane protein (100 pg) was subjected to PAGE (12% gel) under nonreducing conditions. Separated proteins were transferred electrophoretically to a nitrocellulose membrane. Binding proteins were detected by overnight incubation with '*'I-IGF-I1 (i06 cpm) followed by autoradiogra-
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For studies on type I IGF receptor autophosphorylation, receptors were purified by wheat germ lectin afiinity chromatography. Rat liver membranes were extracted with 1 % Triton X-100. The extract (10 mg protein for fetal samples, 25 mg for adult samples) was applied to a 2-mL column of wheat germ lectin-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ) and unbound proteins were applied a second time. The column was washed with 50 mL of 40 mM imidazole-HCl, 0.5 M NaCl, 10% glycerol, 0.05% Triton X-100, pH 7.2. Receptors were then eluted with the same buffer containing 0.3 M N-acetyl glucosamine. Fractions that bound '2SI-insulin (17) were pooled. In previous stud- --I I - 
RESULTS
The binding of IZ5I-IGF-I to fetal and adult rat liver membranes was not displaced by the addition of insulin at concentrations below 0.2 pM (not shown). However, IZ5I-IGF-I was displaced by >80% at 1.3 pM insulin, indicating that the major binding species in our membrane preparations was the type I IGF receptor. Binding to fetal liver membranes from control 2 1-d fetuses (Fig. 1A) was similar to that obtained using membranes from growth-retarded fetuses of fasted mothers (Fig. 1 B) . Liver membrane IGF-I binding capacity decreased after birth ( Fig. 1C and D) . By the 5th postnatal d, binding capacity was decreased by 80 to 90% without a significant change in affinity. At and beyond d 13 of age, affinity and receptor number could not be estimated because of inadequate specific binding.
As was the case for the binding studies, affinity labeling of rat liver membranes with IZ5I-IGF-I was sensitive to inhibition by unlabeled IGF-I (Fig. 2) with insulin having no effect at concentrations below 1 pM. This result is consistent with affinitylabeling of the M, = 135 000 type I IGF receptor a-subunit with insignificant labeling of the insulin receptor a-subunit of the same molecular mass.
Aftinity-labeling of type I IGF receptor a-subunit in fetal membranes (Fig. 3A) increased little with advancing gestation, in contrast to estimates of receptor number based on Scatchard analysis. Intensity of the affinity-labeled type I receptor on d 17 of gestation was 84 + 30% of levels on d 21 (mean of four independent experiments). Affinity-labeling was not altered in term growth-retarded fetuses of fasted mothers.
A comparison of adult and term fetal liver membranes (Fig.  3B) revealed an -90% diminution in affinity-labeling (adult = 1 1 + 6% of term fetal levels; mean of six experiments). Aftinitylabeling of membranes from 1-, 2-, 5-, and 13-d-old rat pups (Fig. 4) showed a gradual decrease of 50% from d 1 to 13. Competition with unlabeled IGF-I and insulin confirmed that this represented a decline in labeling of the type I IGF receptor a-subunit.
T o compare the effects of postnatal fasting with those of intrauterine nutrient deprivation (maternal fasting), fed and fasted (48 h) adult rats were studied (Fig. 5) . Fasting led to a 2-to 3-fold increase in affinity labeling of the type I IGF receptor a-subunit, based on densitometric analysis.
Our data showed a discrepancy between the degree with which binding and affinity-labeling increased before term. To determine if this difference between methods could be attributed to the presence of IGFBP, we analyzed membrane preparations by ligand blot analysis (not shown). A ligand blot of duplicate membrane samples from 17-, 19-, and 21-d fetuses revealed abundant binding with Mr = 3 1 000. The intensity ofthe affinitylabeled band increased by 30 to 50% between 17 and 21 d gestation. An IGFBP with M, -37 000 was also detected at much lower and relatively constant levels in the same samples. The significance of these results are addressed below.
Because signal transmission via the type I IGF receptor probably involves activity of the intrinsic receptor tyrosine kinase, we evaluated this receptor activity. Rather than using an exogenous, nonphysiologic substrate, receptor kinase activity was measured as IGF-I-dependent receptor autophosphorylation. Half-maxima1 receptor phosphorylation occurred between 15 and 30 nM IGF-I (Fig. 6) , indicating specificity of IGF-I for activation of the type I IGF receptor kinase. Type I IGF receptor /3-subunit from 17-, 19-, and 2 1 -d fetal and adult (control and fasted) livers were capable of autophosphorylation at the lowest concentration of IGF-I that elicited maximal phosphorylation (32 nM; Fig. 7) . The degree of receptor autophosphorylation was roughly proportional to receptor content. (Note that 2.5 times more membrane protein was used for receptor purification from adult liver.)
DISCUSSION
Using ligand binding analysis, affinity-labeling, and receptor autophosphorylation studies, we have shown that the type I IGF receptor is present and enzymatically active in fetal rat liver from d 17 of gestation until term. Quantification by competitive binding indicated that receptor levels nearly doubled between d 17 and 21. The expression of the type I IGF receptor in fetal liver during the latter part of gestation is consistent with a role for the IGF in promoting fetal hepatic growth and differentiation. The postnatal decrease in receptor expression seen with both methods is consistent with the developmental regulation of the type I IGF receptor gene (18) , which declines to approximately 70% of term fetal levels by 1 wk of age. Conversely, IGF-I mRNA expression ( 18) shows a marked increase in hepatic levels by 2 wk of age. Thus, the postnatal disappearance of the type I IGF receptor may result from decreased gene expression, in- creased ligand-mediated receptor degradation, or a combination of both.
A difficult aspect of the present studies is ascertainment of the IGF receptors and binding proteins that are measured in the competitive binding assays. The change (-20% increase) in affinity-labeled type I IGF receptor from d 17 to 2 1 of gestation was considerably less than the observed increase in binding capacity. Similarly, the degree with which IGF-I binding decreased during the first 2 wk of life was not reflected in a comparable decrease in affinity-labeling. Fetal (19) and adult (20) rat liver membranes contain type I1 IGF receptors. Our own data demonstrate the presence of IGFBP in hepatic membrane preparations. However, neither type I1 IGF receptors (20) nor IGFBP (21) are susceptible to inhibition of IGF-I binding by insulin. Because >80% of fetal hepatic membrane binding was sensitive to insulin, we conclude that our binding assay mainly measured the type I IGF receptor. The multiple affinity-labeled bands on the more highly exposed autoradiograms (Figs. 4 and 5) probably do not contribute significantly to binding, inasmuch as they were present in samples that had little IGF-I-specific binding.
Similar to the findings of Caro et al. (22) , who studied both adult human hepatocytes and adult rat liver, we detected little IGF-I-specific binding in adult rat liver. However, type I IGF receptors were readily detected by affinity-labeling. This is consistent with the findings of Venkatesan and Davidson (23), who were able to demonstrate the presence of type I IGF receptors in adult rat liver using competitive binding and affinity-labeling. In addition, we found that IGF-I stimulated phosphorylation of a M, = 95 000 protein purified by wheat germ lectin chromatography. Identity of this protein with the @-subunit of the type I IGF receptor is supported by the dose-response curve shown in Figure 6 . Phosphorylation was stimulated at a concentration of IGF-I (32 nM) too low to activate the insulin receptor kinase. Thus, it appears that adult liver membranes contain functional type I IGF receptors.
Fasting of adult rats resulted in a 2.5-fold increase in affinitylabeled type I receptor. This result complements those of Lowe et al. (24) , who also studied the effects of 48 h of fasting in the adult rat on IGF-I binding. These authors did not investigate changes in hepatic binding because basal levels were low. However, our affinity-labeling results indicate an increase comparable to that seen in the heart (24), another organ with relatively low basal binding. It appears that the regulation of type I IGF receptors in liver parallels that in other tissues. This may be a consequence of decreased receptor turnover coincident with diminished hepatic IGF-I synthesis during fasting (1 2,24). These results, taken together with the autophosphorylation studies, are consistent with an autocrine/paracrine action of the IGF in adult liver. This interpretation is supported by the finding that adult rat hepatocytes in culture are stimulated to proliferate by IGF-I at concentrations most consistent with action via the type I receptor (25) .
In contrast to the effects of fasting in the adult rat, limitation of nutrients to the fetal rat via maternal fasting does not lead to a change in IGF-I binding or affinity-labeling. This differs from regulation of the hepatic insulin receptor, which we have shown increases in growth-retarded fetuses of fasted mothers (14) . Fetal rat liver '251-insulin-specific binding and maximum insulin binding calculated from Scatchard analyses correlated inversely with a wide range of diminishing insulin concentrations, consistent with decreased insulin-dependent receptor turnover. Extended interpretation of the present study will require investigation into the effects of fetal nutritional perturbation on fetal hepatic IGF-I secretion. In addition, regulation of receptor kinase sp act represents another mechanism for modulation of IGF effect and is a subject for further investigations.
